TürkiyeResearch and clinical trials
48 Turner patients on growth hormone in Diyarbakır: those who started early reached a greater height
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Diyarbakır, 48 Turner patients who received growth hormone and reached their final height were studied. Treatment started at an average age of 11.7 years and lasted 4.3 years. The average final height was 147.8 cm. 29% of patients rose above the lower limit for their peers. Those who started treatment earlier and had a better starting height gained more height.
What does it mean for patients and families?
In Turner syndrome, early diagnosis appears to be important for height gain. This is a retrospective study from a single region. The timing of treatment should be discussed with a doctor.
Source
Scientific paper: Final Height in Patients with Turner Syndrome Treated With Growth Hormone Therapy. Turkish Archives of Pediatrics, 2025. DOI: 10.5152/TurkArchPediatr.2025.25132 · PubMed 42032939
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Turner syndrome
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.